Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
18 September 2024
Leveraging the US CDC’s National Healthcare Safety Network (NHSN) HAI tracking system to inform AMR R&D
Arjun Srinivasan
30 April 2024 - LB002
In vitro activity of two aztreonam-based combinations, aztreonam/avibactam and aztreonam/nacubactam against molecularly characterised carbapenemase expressing Enterobacterales collected in India
Yamuna Devi Bakthavatchalam, Fiza Abdullah, Devishree Srinivasan, Balaji Veeraraghavan
30 April 2024 - P3214
A prospective study on implementing the ideal time to administer pre - operative antibiotics for cesarean delivery in a south indian secondary care hospital
Sureshkumar Dorairajan, Sowmiya Srinivasan, Sanju Menaka Sivakumar, Saravanan Rajavel, Sakthi Atchitha Sudalai Kannan, Rithika Mari, Santhiya Kuppusamy, Monish Kumar Koteeswaran, Safiya Banu Sadik Basha
30 April 2024 - O1177
Oral zoliflodacin is non-inferior to a combination of ceftriaxone and azithromycin for treatment of uncomplicated urogenital gonorrhoea: results of a large global Phase III randomised controlled trial
Alison Luckey, Helen Broadhurst, Pierre Daram, Sinead Delany-Moretlwe, Henry J. C. De Vries, Rossaphorn Kittiyaowamarn, Drew Lewis, John P. Mueller, Seamus O'Brien, Mary-Ann Richardson, Subasree Srinivasan, Stephanie N. Taylor, Magnus Unemo, Edward W. Hook Rd
29 April 2024 - P1420
In vitro activity of cefiderocol against carbapenem-resistant Pseudomonas aeruginosa (CRPA) clinical isolates from countries with high CRPA incidence, 2019-2022
Renata Da Costa, Nimmi Kothari, Thomas Valmont, Suba Srinivasan, Jennifer Cohn, François Franceschi, Stephen Hawser
29 April 2024 - P1434
In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates from countries with high CRAB incidence, 2019-2022
Renata Da Costa, Nimmi Kothari, Thomas Valmont, Suba Srinivasan, Jennifer Cohn, François Franceschi, Stephen Hawser
29 April 2024 - P1446
In vitro activity of cefiderocol against carbapenem-resistant Enterobacterales (CREs) clinical isolates from countries with high CRE incidence, 2019-2022
Renata Da Costa, Nimmi Kothari, Thomas Valmont, Suba Srinivasan, Jennifer Cohn, François Franceschi, Stephen Hawser
29 April 2024 - E0900
Comparison of outcomes of clinically significant breakthrough CMV infections while on letermovir prophylaxis or while on pre-emptive strategy in allogeneic haematopoietic cell transplant recipients
Marilyne Daher, Fareed Khawaja, Amy Spallone, Joseph Sassine, Anthony Febres Aldana, Oscar Morado, Krithika Srinivasan, Ella Ariza-Heredia, Roy F. Chemaly
28 April 2024 - P2724
Safety profile of oral zoliflodacin for uncomplicated gonorrhoea in a Phase 3 trial
Gabrielle Kornmann, Hilary Johnstone, Tanyaporn Wanson, Subasree Srinivasan, Drew Lewis, Alison Luckey
28 April 2024 - P2527
Antimicrobial susceptibility of baseline Neisseria gonorrhoeae isolates from participants recruited in the global zoliflodacin Phase 3 randomised controlled trial
Alison Luckey, Varalakshmi Elango, Esther Bettiol, Laura J. V. Piddock, Magnus Unemo, Patricia Bradford, Sarah Mcleod, John P. Mueller, Subasree Srinivasan
15 April 2023 - P0091
Searching for carbapenem-sparing regimens to treat ESBL-producing Enterobacterales (ESBL-PE): in vitro susceptibility evaluation of a current global panel of ESBL-PE to selected antibiotics
Renata Da Costa, Nimmi Kothari, Thomas Valmont, Suba Srinivasan, François Franceschi, Stephen Hawser
26 April 2022 - O0817
Efficacy and safety of sulbactam-durlobactam (SUL-DUR) versus colistin therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections: a global, randomised, active-controlled phase III trial (ATTACK)
David Altarac, Robin Isaacs, Subasree Srinivasan, Sarah Mcleod, Khurram Rana, Gabrielle Poirier, Andrew Shorr, Keith Kaye
23 April 2022 - P1374
Pharmacokinetic and pharmacodynamic (PK/PD) characterisation of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model
Jennifer Hoover, Christine Singley, Meenakshi Srinivasan, Abhinav Kurumaddali
23 April 2022 - P0504
Hypervirulent colistin resistant Klebsiella pneumoniae: rising superbugs among endemic nosocomial clones
Chaitra Shankar, Abirami Shankar, Swathi Srinivasan, Sathiya Shanmugam, Abi Manesh, Binesh Lal Yesudhason, Balaji Veeraraghavan
23 April 2022 - P1397
Efficacy and safety of sulbactam-durlobactam (SUL-DUR) therapy in patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections in the open label part B of the ATTACK phase III trial
David Altarac, Robin Isaacs, Subasree Srinivasan, Sarah Mcleod, Khurram Rana, Gabrielle Poirier, Andrew Shorr, Keith Kaye
23 April 2022 - P1365
Inhibition of renal OCT/MATE transport by cimetidine does not impact gepotidacin
Maciej Zamek-Gliszczynski, Jeremy Dennison, Janet Flemming, Jamie Maygar, Marcy Powell, Shaila Shabbir, Sebin Thomas, Etienne Dumont, Meenakshi Srinivasan, Brandon Swift, Aline Barth
23 April 2022 - P1366
An overview of drug-drug interactions with the novel, first-in-class triazaacenaphthylene antibiotic gepotidacin
Aline Barth, Jeremy Dennison, Maciej Zamek-Gliszczynski, Janet Flemming, Jamie Maygar, Marcy Powell, Shaila Shabbir, Sebin Thomas, Etienne Dumont, Meenakshi Srinivasan, Brandon Swift
15 April 2019 - P1953
Population pharmacokinetic and pharmacokinetic-pharmacodynamic target attainment analyses of ETX2514SUL to support dosing regimens in patients with varying renal function
Nikolas J. Onufrak, Christopher M. Rubino, Paul G. Ambrose, Robin Isaacs, Subasree Srinivasan, John O'Donnell
13 April 2019 - O0300
A double-blind, randomised, placebo-controlled study to evaluate the safety and efficacy of intravenous sulbactam-ETX2514 in the treatment of hospitalised adults with complicated urinary tract infections, including acute pyelonephritis
Subasree Srinivasan, Olexiy Sagan, Ruslan Yakubsevitch, Krassimir Yanev, Roman Fomkin, Emily Stone, Daniel Hines, John O'Donnell, Alita Miller, Robin Isaacs
21 April 2018 - P0387
Correlation of high-risk antibiotic use and hospital-associated C. difficile infections: data from 195 US hospitals
Vladimir Havlicek, Y. Tabak, A. Srinivasan, S. Gelone, S. Kurtz, V. Gupta, P. Scoble, L. McDonald
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.